Document is current
Any future updates will be listed below
-
Authors
Manzo, Julia
Puhalla, Shannon
Pahuja, Shalu
Ding, Fei
Lin, Yan
Appleman, Leonard
Tawbi, Hussein
Stoller, Ronald
Lee, James J.
Diergaarde, Brenda
Kiesel, Brian F.
Yu, Jing
Tan, Antoinette R.
Belani, Chandra P.
Chew, Helen
Garcia, Agustin A.
Morgan, Robert J.
Wahner Hendrickson, Andrea E.
Visscher, Daniel W.
Hurley, Rachel M.
Kaufmann, Scott H.
Swisher, Elizabeth M.
Oesterreich, Steffi
Katz, Tiffany
Ji, Jiuping
Zhang, Yiping
Parchment, Ralph E.
Chen, Alice
Duan, Wenrui
Giranda, Vincent
Shepherd, Stacie P.
Ivy, S. Percy
Chu, Edward
Beumer, Jan H. https://orcid.org/0000-0002-8978-9401
,
-
Funding
Funding for this research was provided by:
National Cancer Institute (U01CA099168, U24CA247643, UM1CA186690, P30CA047904, R01CA190423, HHSN261200800001E)
National Institutes of Health (UL1TR001857)
- License Information
-
More Information
Article History
Received: 7 January 2022
Accepted: 27 March 2022
First Online: 18 April 2022
Declarations
:
: Jan Beumer received research support from AbbVie and has consulted as expert witness on behalf of Pfizer and Spectrum Pharmaceuticals. Shannon Puhalla has received research support from AbbVie, Pfizer, Lilly, Novartis, Incyte, Covance-Bayer, AstraZeneca, Genentech, Medivation and has been a consultant for AbbVie, MedImmune, Celldex, Puma, Pfizer, AstraZeneca, Esai, and Nanostring.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This trial was registered under ClinicalTrials.gov Identifier: NCT01154426.
: Informed consent was obtained from all individual participants included in the study.
